1-5 of 5
Shu Xing
Close
Sort by
Journal Articles

Generation and Characterization of Transgenic Mice Expressing MplW515L.

Wanming Zhao, Shu Xing, Rufei Gao, Aref Al-Kali, MD, Wanting Tina Ho, Zhizhuang Joe Zhao, Ph.D
Journal: Blood
Blood (2009) 114 (22): 3901.
https://doi.org/10.1182/blood.V114.22.3901.3901
Published: 2009
Journal Articles

Transgenic Expression of Wild Type JAK2 Suppresses Myeloproliferative Disorder Phenotypes Induced by Mutant JAK2V617F in Mice

Shu Xing, Wanming Zhao, Wanting Tina Ho, Zhizhuang Joe Zhao
Journal: Blood
Blood (2008) 112 (11): 180.
https://doi.org/10.1182/blood.V112.11.180.180
Published: 2008
Journal Articles

Transgenic expression of JAK2 V617F causes myeloproliferative disorders in mice

Shu Xing, Tina Ho Wanting, Wanming Zhao, Junfeng Ma, Shaofeng Wang, Xuesong Xu, Qingshan Li, Xueqi Fu, Mingjiang Xu, Zhizhuang Joe Zhao
Journal: Blood
Blood (2008) 111 (10): 5109–5117.
https://doi.org/10.1182/blood-2007-05-091579
Published: 2008
Includes: Supplemental data
Journal Articles

Transgenic Expression of JAK2 V617F Causes Myeloproliferative Disorders in Mice.

Shu Xing, MS, Zhizhuang Joe Zhao, Ph.D
Journal: Blood
Blood (2007) 110 (11): 2527.
https://doi.org/10.1182/blood.V110.11.2527.2527
Published: 2007
Journal Articles

JAK2 V617F : prevalence in a large Chinese hospital population

Clinical Trials & Observations Brief Report
Xuesong Xu, Qi Zhang, Jian Luo, Shu Xing, Qingshan Li, Sanford B. Krantz, Xueqi Fu, Zhizhuang Joe Zhao
Journal: Blood
Blood (2006) 109 (1): 339–342.
https://doi.org/10.1182/blood-2006-03-009472
Published: 2006
Includes: Supplemental data